DYSLIPIDAEMIAS IN WHITE AND BLACK TREATED ESSENTIAL HYPERTENSIVE PATIENTS

被引:0
|
作者
MAZZAROLOCRUZ, HM [1 ]
CRUZ, J [1 ]
机构
[1] UNIV SAO PAULO,HOSP & CLIN,FAC MED,INST CENT,DIV NEFROL,BR-05508 SAO PAULO,BRAZIL
关键词
DYSLIPIDAEMIAS; BLACKS; WHITES;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Serum lipid profiles were evaluated in 143 white (31 men, 112 women, aged 58.4+/-0.9 years) and in 75 black individuals (16 men, 59 women, aged 52.6+/-1.0 years) with treated essential hypertension. Hypertension onset was earlier in the blacks than the whites (39.7+/-1.0 vs. 46.6+/-1.1 years). Duration of hypertension was similar in both races (11.8+/-1.0 and 12.9+/-1.0 years) and did not correlate with serum lipid values. Mean serum lipids, excluding HDL-C, were significantly higher in white than in black hypertensives (LDL-C 4.19+/-0.08 vs. 3.82+/-0.13; TG 1.80+/-0.10 vs. 1.40+/-0.09 mmol/l; LDL-C/HDL-C 4.0+/-0.1 vs. 3.6+/-0.2). The prevalence of dyslipidaemia was significantly higher in white than in black patients (64% vs. 52%). Types IIa, IIb and IV were more prevalent in whites and isolated low HDL-C in blacks. Obesity was found in 27% of the whites and 31% of the blacks. Hypertriglyceridaemia was more frequent in obese hypertensives of both races, but mostly among the white obese patients. Among lipid values within the normal range, the mean levels of serum lipids were similar in both races, with the exception of triglyceridaemia, which was significantly lower in black than in white hypertensives. These findings may be attributed to racial differences rather than to nutritional trends.
引用
收藏
页码:831 / 835
页数:5
相关论文
共 50 条
  • [21] Doxazosin addition improves microcirculation and reduces microalbuminuria in treated essential hypertensive patients
    Cosenzi, A.
    Bernobich, E.
    Borri, A.
    Tomasella, S.
    Ban, A.
    Kogoj, P.
    Trevisan, G.
    Bellini, G.
    JOURNAL OF HYPERTENSION, 2006, 24 : S400 - S400
  • [22] Pharmacokinetic–Pharmacodynamic Modeling of the Antihypertensive Effect of Eprosartan in Black and White Hypertensive Patients
    Petra C. van Rijn-Bikker
    Oliver Ackaert
    Nelleke Snelder
    Reinier M. van Hest
    Bart A. Ploeger
    Richard P. Koopmans
    Ron A. A. Mathôt
    Clinical Pharmacokinetics, 2013, 52 : 793 - 803
  • [23] Relationship between structural parameters and haemodynamics in essential hypertensive patients treated with candesartan
    Costa, R
    Crippa, M
    Notaristefano, I
    Pagnoni, N
    Chiari, E
    Fariello, R
    JOURNAL OF HYPERTENSION, 2000, 18 : S154 - S154
  • [24] Regression of electrocardiographic left ventricular hypertrophy in essential hypertensive patients treated with irbesartan
    Espino Montoro, A.
    Castilla Guerra, L.
    Alvarez Lacayo, C.
    Villalba Alcala, F.
    Gonzalez Fernandez, M. C.
    Lopez Chozas, J. M.
    JOURNAL OF HYPERTENSION, 2007, 25 : S362 - S363
  • [25] Hyperinsulinemia and left ventricular mass in non treated essential hypertensive patients.
    Cardona, E
    Leal, A
    Sanchez, S
    Lopez, A
    Noriega, J
    Gonzalez, M
    Martinez, E
    HYPERTENSION, 1997, 29 (03) : 191 - 191
  • [26] ERYTHROCYTE COTRANSPORT IN WHITE AND BLACK HYPERTENSIVE SUBJECTS
    CROOK, JE
    MROCZKOWSKI, PJ
    CLINICAL RESEARCH, 1982, 30 (04): : A733 - A733
  • [27] CAN PULSE PRESSURE PREDICT WHITE COAT EFFECT IN TREATED HYPERTENSIVE PATIENTS?
    Ahn, Youngkeun
    Yoon, Hyun Ju
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E560 - E560
  • [28] THE PREVALENCE OF WHITE-COAT EFFECT AND REVERSE WHITE-COAT EFFECT IN TREATED HYPERTENSIVE PATIENTS
    Lewandowska, Katarzyna
    Lipski, Dawid
    Pawlak-Chomicka, Regina
    Uruski, Pawel
    Tykarski, Andrzej
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E211 - E211
  • [29] Silent cerebral white matter lesions in middle-aged essential hypertensive patients
    Sierra, C
    de la Sierra, A
    Mercader, J
    Gómez-Angelats, E
    Urbano-Márquez, A
    Coca, A
    JOURNAL OF HYPERTENSION, 2002, 20 (03) : 519 - 524
  • [30] Stable plasma magnesium status in essential hypertensive patients treated with angiotensin II antagonists
    Kisters, K
    Wessels, F
    Tokmak, F
    Hausberg, M
    Barenbrock, M
    Kosch, M
    MAGNESIUM-BULLETIN, 2000, 22 (04): : 92 - 94